Tech For Longevity
ACCUEIL
REPLAYS
DEMOZONE
INTERVENANTS
À PROPOS
en
fr
Participer à la session
🇬🇧 From AI to Longevity: Investing in the Future of Human Potential
20 nov. 2024
—
15:45 CET
-
15:59 CET
Présentée par
HO
Henri-Nicolas
OLIVIER
Maison Epigenetic
Co-Founder & CEO
CB
Charles-Edouard
BOUEE
Adagia Partners
Co-Founder and Managing Partner
Présentée
par
CB
Charles-Edouard
BOUEE
Co-Founder and Managing Partner
HO
Henri-Nicolas
OLIVIER
Co-Founder & CEO
Sessions
recommandées
20 nov.
15:00
-
15:10
🇬🇧 Opening Tech for Longevity
HO
Henri-Nicolas
OLIVIER
Maison Epigenetic
Co-Founder & CEO
DG
Damien
Gromier
AI for Health by Artefact
CEO of Artefact Open Innovation & Founder of AI for Health
20 nov.
15:10
-
15:25
🇬🇧 The longevity investment landscape
PN
Phil
Newman
Longevity.Technology
CEO & Founder
20 nov.
15:25
-
15:45
🇬🇧 The $600 Billion Longevity Boom: Unlocking Investment Opportunities in the Age of Aging
MS
Montse
Suarez
IRIS Ventures
Founder & Managing Partner
AL
Arnaud
Laurent
OVNI Capital
Founding partner
AP
Anaïs
Pons
Eurazeo Brands
Principal
HO
Henri-Nicolas
OLIVIER
Maison Epigenetic
Co-Founder & CEO
20 nov.
15:59
-
16:18
🇬🇧 The Longitudinal health revolution: Uniting genetics, Functional lab tests, and 21st century...
CM
Chris
Moore
Nordic Group
Co-founder and CEO
HO
Henri-Nicolas
OLIVIER
Maison Epigenetic
Co-Founder & CEO
